BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.
Also called NCT07181590
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07181590
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Poland, Portugal, Spain, Sweden
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07181590. Allocation not applicable; no masking; primary purpose treatment. Start 2025-12-11 (actual); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
- Acronym
- BLAST-OFF
- Condition
- Paroxysmal AF
- Condition
- Atrial Arrhythmia
- Condition
- Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct07181590- Content hash
763feae1b0041aedf27425e37a9685f10f0fbfaf8265605aea905c3677f4d444